Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen, +617

The Lancet Oncology

5-Year AnalysisBreast OncologyOncologyHealth SciencesClinical Trials +8

Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

Hyman B. Muss, Donald A. Berry, Constance Cirrincione, +21

New England Journal of Medicine

The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II–Positive Breast Cancer Treated With Adjuvant Trastuzumab Therapy

Nazanin Fallah‐Rad, Jonathan R. Walker, Anthony Wassef, +9

Journal of the American College of Cardiology

Tissue VelocityCardiomyopathyBreast OncologyHealth SciencesMedicine +9

Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study

Deepa Wadhwa, Nazanin Fallah‐Rad, Debjani Grenier, +8

Breast Cancer Research and Treatment

Retrospective StudyBreast OncologyMedicinePharmacologyAdjuvant Chemotherapy +5

Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104

Ann H. Partridge, Laura Archer, Alice B. Kornblith, +10

Journal of Clinical Oncology

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

Hyman B. Muss, Mei‐Yin C. Polley, Donald A. Berry, +25

Journal of Clinical Oncology

Bone mineral density and risk of postmenopausal breast cancer

Debjani Grenier, Andrew Cooke, Lisa M. Lix, +3

Breast Cancer Research and Treatment

Bone HealthMedicineBone Mineral DensityBreast CancerMenopause +5

Promoting consultation recording practice in oncology: identification of critical implementation factors and determination of patient benefit

Thomas F. Hack, Joseph D. Ruether, Lorna Weir, +2

Psycho-Oncology

Neoadjuvant Therapy for Breast Cancer: Updates and Proceedings From the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer

Angel Arnaout, J. Lee, Karen A. Gelmon, +9

Current Oncology

Surgical OncologyBreast OncologyNeoadjuvant TherapyCanadian ConsortiumMedicine +11

Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake

Julian O. Kim, Daniel J. Schaid, Celine M. Vachon, +12

Cancer Prevention Research